| | | 33998 | | 04.06.1968 | | Aspen Pharma Schweiz GmbH | | 12.12.2007 | | | | | | | | | | | 01.02.20. | | | | 01.02.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Carbostesin-Adrenalin 0,25 % | Injektionslösung | Injection solution (Bupivacain Hydrochloride Anhydride 2.5 mg/ml, Adrenaline 5 µg/ml) | N01BB51 | | | 02 | Carbostesin-Adrenalin 0,5 % | Injektionslösung | Injection solution (Bupivacain Hydrochloride Anhydride 5 mg/ml, Adrenaline 5 µg/ml) | N01BB51 | |
|
|
